IQVIA (NYSE:IQV) Releases FY 2024 Earnings Guidance

IQVIA (NYSE:IQV) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 11.100-11.200 for the period, compared to the consensus EPS estimate of 11.210. The company issued revenue guidance of $15.4 billion-$15.4 billion, compared to the consensus revenue estimate of $15.5 billion. IQVIA also updated its FY24 guidance to $11.10-11.20 EPS.

Analysts Set New Price Targets

IQV has been the topic of several recent analyst reports. JPMorgan Chase & Co. decreased their price target on IQVIA from $288.00 to $279.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 23rd. Redburn Atlantic began coverage on shares of IQVIA in a research report on Monday, October 14th. They set a “buy” rating and a $276.00 target price for the company. Jefferies Financial Group lowered shares of IQVIA from a “buy” rating to a “hold” rating and reduced their price target for the company from $266.00 to $242.00 in a research report on Wednesday, July 24th. Truist Financial lowered their target price on IQVIA from $300.00 to $286.00 and set a “buy” rating for the company in a research note on Monday, October 14th. Finally, StockNews.com raised IQVIA from a “hold” rating to a “buy” rating in a report on Wednesday. Four investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $261.24.

IQVIA Trading Up 1.6 %

Shares of IQV stock traded up $3.34 during trading hours on Friday, reaching $209.16. The company had a trading volume of 1,791,887 shares, compared to its average volume of 1,125,496. The company has a debt-to-equity ratio of 1.76, a current ratio of 0.81 and a quick ratio of 0.85. IQVIA has a 1-year low of $181.03 and a 1-year high of $261.73. The company has a 50 day moving average of $234.31 and a 200 day moving average of $229.74. The firm has a market cap of $38.13 billion, a price-to-earnings ratio of 27.45, a P/E/G ratio of 2.01 and a beta of 1.51.

Insiders Place Their Bets

In related news, insider Eric Sherbet sold 1,300 shares of the business’s stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the completion of the transaction, the insider now owns 19,536 shares in the company, valued at approximately $4,812,302.88. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.60% of the company’s stock.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.